SEI Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $481K | Sell |
21,261
-2,513
| -11% | -$55.8K | ﹤0.01% | 2665 |
|
|
2025
Q4 | $615K | Sell |
23,774
-1,298
| -5% | -$30.9K | ﹤0.01% | 2418 |
|
|
2025
Q3 | $646K | Sell |
25,072
-285
| -1% | -$7K | ﹤0.01% | 2134 |
|
|
2025
Q2 | $606K | Buy |
25,357
+2,772
| +12% | +$69.9K | ﹤0.01% | 2104 |
|
|
2025
Q1 | $561K | Buy |
22,585
+7,658
| +51% | +$183K | ﹤0.01% | 2106 |
|
|
2024
Q4 | $281K | Sell |
14,927
-7,231
| -33% | -$127K | ﹤0.01% | 2379 |
|
|
2024
Q3 | $334K | Sell |
22,158
-26,525
| -54% | -$453K | ﹤0.01% | 2315 |
|
|
2024
Q2 | $1.39M | Buy |
48,683
+19,860
| +69% | +$565K | ﹤0.01% | 1787 |
|
|
2024
Q1 | $842K | Buy |
28,823
+575
| +2% | +$17.7K | ﹤0.01% | 1945 |
|
|
2023
Q4 | $953K | Sell |
28,248
-18,519
| -40% | -$542K | ﹤0.01% | 1888 |
|
|
2023
Q3 | $1.43M | Sell |
46,767
-2,376
| -5% | -$85.6K | ﹤0.01% | 1747 |
|
|
2023
Q2 | $1.97M | Buy |
49,143
+668
| +1% | +$27.6K | ﹤0.01% | 1637 |
|
|
2023
Q1 | $1.98M | Buy |
48,475
+10,925
| +29% | +$435K | ﹤0.01% | 1631 |
|
|
2022
Q4 | $1.45M | Sell |
37,550
-52,604
| -58% | -$2.56M | ﹤0.01% | 1628 |
|
|
2022
Q3 | $4.79M | Sell |
90,154
-1,652
| -2% | -$91.9K | 0.01% | 1109 |
|
|
2022
Q2 | $5.39M | Buy |
91,806
+37,958
| +70% | +$2.49M | 0.01% | 1055 |
|
|
2022
Q1 | $4.11M | Buy |
53,848
+5,539
| +11% | +$369K | 0.01% | 1214 |
|
|
2021
Q4 | $2.93M | Buy |
48,309
+1,578
| +3% | +$87K | 0.01% | 1409 |
|
|
2021
Q3 | $2.65M | Buy |
46,731
+2,895
| +7% | +$167K | 0.01% | 1385 |
|
|
2021
Q2 | $2.68M | Buy |
43,836
+6,196
| +16% | +$392K | 0.01% | 1374 |
|
|
2021
Q1 | $2.57M | Buy |
37,640
+2,009
| +6% | +$144K | 0.01% | 1343 |
|
|
2020
Q4 | $2.16M | Sell |
35,631
-26,539
| -43% | -$1.55M | 0.01% | 1350 |
|
|
2020
Q3 | $3.76M | Sell |
62,170
-7,323
| -11% | -$425K | 0.01% | 1006 |
|
|
2020
Q2 | $3.67M | Buy |
69,493
+9,545
| +16% | +$399K | 0.01% | 991 |
|
|
2020
Q1 | $2.03M | Buy |
59,948
+12,778
| +27% | +$531K | 0.01% | 1137 |
|
|
2019
Q4 | $2.2M | Buy |
47,170
+22,826
| +94% | +$969K | 0.01% | 1305 |
|
|
2019
Q3 | $927K | Buy |
24,344
+1,847
| +8% | +$73.7K | ﹤0.01% | 1633 |
|
|
2019
Q2 | $979K | Buy |
22,497
+10,088
| +81% | +$428K | ﹤0.01% | 1610 |
|
|
2019
Q1 | $471K | Sell |
12,409
-16,169
| -57% | -$631K | ﹤0.01% | 1923 |
|
|
2018
Q4 | $1.31M | Buy |
28,578
+14,662
| +105% | +$684K | ﹤0.01% | 1445 |
|
|
2018
Q3 | $685K | Buy |
13,916
+10,923
| +365% | +$472K | ﹤0.01% | 1574 |
|
|
2018
Q2 | $96K | Buy |
2,993
+1,172
| +64% | +$40.5K | ﹤0.01% | 2301 |
|
|
2018
Q1 | $57K | Sell |
1,821
-93
| -5% | -$3.31K | ﹤0.01% | 2315 |
|
|
2017
Q4 | $88K | Sell |
1,914
-23,625
| -93% | -$936K | ﹤0.01% | 2189 |
|
|
2017
Q3 | $959K | Sell |
25,539
-14,956
| -37% | -$602K | ﹤0.01% | 1468 |
|
|
2017
Q2 | $1.93M | Buy |
40,495
+17,388
| +75% | +$807K | 0.01% | 1206 |
|
|
2017
Q1 | $1.05M | Sell |
23,107
-35
| -0.2% | -$1.51K | ﹤0.01% | 1372 |
|
|
2016
Q4 | $747K | Buy |
23,142
+8,071
| +54% | +$269K | ﹤0.01% | 1459 |
|
|
2016
Q3 | $516K | Buy |
15,071
+12,155
| +417% | +$476K | ﹤0.01% | 1449 |
|
|
2016
Q2 | $98K | Sell |
2,916
-2,408
| -45% | -$118K | ﹤0.01% | 1746 |
|
|
2016
Q1 | $282K | Sell |
5,324
-5,203
| -49% | -$304K | ﹤0.01% | 1443 |
|
|
2015
Q4 | $808K | Sell |
10,527
-4,475
| -30% | -$253K | ﹤0.01% | 1252 |
|
|
2015
Q3 | $617K | Buy |
+15,002
| New | +$919K | 0.01% | 1207 |
|
|
2015
Q1 | – | Sell |
-5,100
| Closed | -$452K | – | 2329 |
|
|
2014
Q4 | $452K | Buy |
+5,100
| New | +$482K | ﹤0.01% | 1184 |
|
Other funds holding PCRX
DPCM
VPM
VCM
